Compare Amylx Pharmaceuticals Inc (AMLX) vs Air Products & Chemicals, Inc. (APD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Air Products & Chemicals, Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.88B). The key difference: Air Products & Chemicals, Inc. is far larger — about 26.1× Amylx Pharmaceuticals Inc's market cap, and Air Products & Chemicals, Inc. pays a 2.34% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | APD | |
|---|---|---|
Market Cap | $2.64B | $68.88B |
Sector | Health | Basic Materials |
52-Week High | $24.19 | $314.19 |
52-Week Low | $7.82 | $230.42 |
Enterprise Value | $2.39B | $86.06B |
Dividend Yield | — | 2.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Air Products & Chemicals, Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →
